Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
05/09/2025 | Q1 2025 | N/A | $0.06 | N/A | N/A | $42.00 K |
03/28/2025 | Q4 2024 | N/A | -$0.06 | N/A | N/A | $82.00 K |
11/08/2024 | Q3 2024 | N/A | $0.08 | N/A | N/A | $42.00 K |
08/09/2024 | Q2 2024 | N/A | -$0.06 | N/A | N/A | $57.00 K |
05/10/2024 | Q1 2024 | N/A | -$0.05 | N/A | N/A | $0 |
03/08/2024 | Q4 2023 | N/A | -$0.07 | N/A | N/A | $4.48 M |
09/29/2023 | Q3 2023 | N/A | -$0.08 | N/A | N/A | $0 |
08/11/2023 | Q2 2023 | N/A | -$0.08 | N/A | N/A | $0 |
05/05/2023 | Q1 2023 | N/A | $0.08 | N/A | N/A | $0 |
03/31/2023 | Q4 2022 | N/A | -$0.11 | N/A | N/A | $14.00 K |
11/10/2022 | Q3 2022 | N/A | -$0.09 | N/A | N/A | $8.00 K |
08/11/2022 | Q2 2022 | N/A | -$0.11 | N/A | N/A | $44.00 K |
05/12/2022 | Q1 2022 | N/A | -$0.13 | N/A | N/A | $68.00 K |
12/31/2021 | Q4 2021 | N/A | $1.02 | N/A | N/A | $165.00 K |
11/10/2021 | Q3 2021 | N/A | -$0.09 | N/A | N/A | $140.00 K |
06/30/2021 | Q2 2021 | N/A | -$0.21 | N/A | N/A | $109.00 K |
05/20/2021 | Q1 2021 | N/A | -$0.10 | N/A | N/A | $157.00 K |
12/31/2020 | Q4 2020 | N/A | -$0.12 | N/A | N/A | $221.00 K |
11/19/2020 | Q3 2020 | N/A | -$0.09 | N/A | N/A | $50.00 K |
06/30/2020 | Q2 2020 | N/A | -$0.17 | N/A | N/A | $52.00 K |
Entera Bio Ltd. WT EXP 062723 has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based offlast year's report dates.
The conference call for Entera Bio Ltd. WT EXP 062723's latest earnings report can be listened to online.
The conference call transcript for Entera Bio Ltd. WT EXP 062723's latest earnings report can be read online.
Entera Bio Ltd. WT EXP 062723 (:ENTXW) has a recorded annual revenue of $181.00 K.
Entera Bio Ltd. WT EXP 062723 (:ENTXW) has a recorded net income of $-9,541,000.Entera Bio Ltd. WT EXP 062723 has generated $-0.25 earnings per share over the last four quarters.
Entera Bio Ltd. WT EXP 062723 (:ENTXW) has a price-to-earnings ratio of -17.45 and price/earnings-to-growth ratio is -0.14.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED